PDL BioPharma (PDLI) is traded on NASDAQ in USA. It is located in NEVADA, U.S.A and employs 87 people. PDL BioPharma is listed under Pharmaceutical Products category by Fama And French industry classification.The company currently falls under 'Small-Cap' category with current market capitalization of 446.05 M. PDL BioPharma conducts business under Healthcare
sector and is part of Pharmaceutical Products
industry. This company has 153.81 M outstanding shares of which 19.07 M shares are at this time shorted by private and institutional investors with about 9.16 trading days to cover.
PDL BIOPHARMA INC currently holds about 532.11 M in cash with 40.62 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.46 which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check PDL BioPharma Probability Of Bankruptcy